ARTICLE | Management Tracks
New CEOs at Evox and George Medicines
Plus: Stoke hires Thomas Leggett as CFO, and updates from TScan, Rinri, Tevogen and more
April 30, 2024 12:02 AM UTC
Evox Therapeutics Ltd. named CBO Per Lundin as CEO and board member, succeeding Antonin “Tony” de Fougerolles, who will become strategic adviser to the company. Lundin co-founded Evox in 2016 to create exosome-based therapies and served as COO before becoming CBO in 2021.
Mark Mallon became CEO and board member of George Medicines Pty. Ltd., which is developing therapies for cardiometabolic disease. Mallon a 24-year veteran of AstraZeneca plc (LSE:AZN; NASDAQ:AZN), previously held CEO roles at Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) and NeoGenomics Inc. (NASDAQ:NEO)...